Showing results (181-190 of 276) with videos related to
Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Types of cyclic AMP binding proteins in human breast cancersW R Miller, M J Hulme, Y S Cho-Chung, et al.British Journal of Cancer|August 15, 2002
Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancerT J Anderson, J M Dixon, M Stuart, et al.British Journal of Cancer|April 20, 2006
Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatmentW R Miller, T J Anderson, J M Dixon, et al.European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifenW R Miller, J M Dixon, L Macfarlane, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1987
Evidence that epichlorohydrin is not a toxic metabolite of 1,2-dibromo-3-chloropropaneR Gingell, P W Beatty, H R Mitschke, et al.Breast (Edinburgh, Scotland)|January 21, 2004
Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancerR A Hawkin, M J Arends, A A Ritchie, et al.The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1997
Regulation of aromatase activity within the breastW R Miller, P Mullen, P Sourdaine, et al.British Journal of Cancer|February 1, 1990
Cyclic AMP binding proteins and prognosis in breast cancerW R Miller, R A Elton, J M Dixon, et al.British Journal of Cancer|November 1, 1987
DNA analysis of breast tumour fine needle aspirates using flow cytometryP A Levack, P Mullen, T J Anderson, et al.Nature|January 17, 1985
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistW R Miller, W N Scott, R Morris, et al.Pageof 28